Arcato Laboratories, Inc. (https://www.arcato-labs.com/) today simultaneously announced successful top line results from its first-in-human Phase 1 study of ARC-001 Gel in patients following third molar (wisdom tooth) extraction surgery, as well as the closing of its first round of financing. ARC-001 Gel is a novel, proprietary, sustained-release, single-dose gel formulation combining three well-characterized, non-addictive anesthetics: […]